Genae's expansion binge brings it a U.K. foothold

Belgian medical device CRO Genae has landed in London, giving the fast-growing company a presence in the U.K. as it stretches its reach across Europe. The U.K. is host to one of the world's largest med tech markets, according to Genae, valued at about $8.9 billion in 2012 and pegged for 6% annual growth through 2017. The London move follows recent expansions into Poland, Germany and Switzerland. Release

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.